Cargando…
Mechanism of CK2.3, a Novel Mimetic Peptide of Bone Morphogenetic Protein Receptor Type IA, Mediated Osteogenesis
Background: Osteoporosis is a degenerative skeletal disease with a limited number of treatment options. CK2.3, a novel peptide, may be a potential therapeutic. It induces osteogenesis and bone formation in vitro and in vivo by acting downstream of BMPRIA through releasing CK2 from the receptor. Howe...
Autores principales: | Vrathasha, Vrathasha, Weidner, Hilary, Nohe, Anja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567251/ https://www.ncbi.nlm.nih.gov/pubmed/31117181 http://dx.doi.org/10.3390/ijms20102500 |
Ejemplares similares
-
Mechanisms of Cellular Internalization of Quantum Dot® Conjugated Bone Formation Mimetic Peptide CK2.3
por: Vrathasha, Vrathasha, et al.
Publicado: (2018) -
Bone Morphogenetic Protein-2 Conjugated to Quantum Dot(®)s is Biologically Functional
por: Halloran, Daniel, et al.
Publicado: (2020) -
CK2.1, a bone morphogenetic protein receptor type Ia mimetic peptide, repairs cartilage in mice with destabilized medial meniscus
por: Akkiraju, Hemanth, et al.
Publicado: (2017) -
CK2.3, a Mimetic Peptide of the BMP Type I Receptor, Increases Activity in Osteoblasts over BMP2
por: Weidner, Hilary, et al.
Publicado: (2019) -
Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice
por: Nguyen, John, et al.
Publicado: (2018)